FDA Recalls Iron Supplement Due to Drug Injury Risks
Jan. 23, 2013
The U.S. Food and Drug Administration (FDA) recently announced a voluntary recall of 100 count bottles of its 325 mg Ferrous Sulfate tablets conducted by Advance Pharmaceutical, Inc. A press release explained the recall is due to a packaging error that could result in serious side effects.
Ferrous Sulfate is a mineral supplement taken by those suffering from an iron deficiency. Problems with the medication surfaced on Dec. 28, 2012, when a pharmacist reported to have received a bottle of Ferrous Sulfate that instead contained 25 mg tablets of Meclizine.
Meclizine can be dangerous when taken with alcohol or other sedatives, an existing CNS Disorder, imprinted liver or kidney function, or when taken by the elderly, infants, or lactating mothers. It can cause a range of Drug Injuries, including impaired alertness, drowsiness, confusion, low blood pressure, coma, and even death.
Anyone in possession of the recalled product should halt its use immediately and contact the manufacturer. Those who have experienced any adverse events associated with the medication mix-up are encouraged to contact the FDA.
The Colorado Springs Personal Injury Lawyers at McDivitt Law Firm hope this recall information can help prevent future drug injuries, and urge anyone who has suffered an adverse health event due to a defective drug to discuss their legal rights with a qualified attorney.Back to the Blog